Garmezy, B., Herzberg, B., Devarakonda, S., Parikh, K., Zarrabi, K. K., Salkeni, M. A., Song, M. M., Segar, J. M., Xiong, H. Q., Sahebjam, S., Liu, E., Graef, T., Sachdev, J. C., Beaupre, D. M., Ahnert, J. R. (2026). IDE892 as monotherapy and in combination with IDE397 in patients with 5-methylthioadenosine phosphorylase-deleted (
                    <i>MTAP</i>
                    -Del) advanced solid tumors (IDE892001): Phase 1 trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps3182